W975 (Divalproex Sodium Delayed-Release 500 mg)

Pill with imprint W975 is White, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Wockhardt USA.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W975

Divalproex Sodium Delayed-Release

Imprint

W975

Strength

500 mg

Color

White

Size

19.00 mm

Shape

Elliptical / Oval

Availability

Prescription only

Drug Class

Fatty acid derivative anticonvulsants

Pregnancy Category

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine

CSA Schedule

Not a controlled drug

Labeler / Supplier

Wockhardt USA

National Drug Code (NDC)

64679-0975

Inactive Ingredients

microcrystalline cellulose, croscarmellose sodium, dimethicone, hypromelloses, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, polysorbate 80, povidone, silicon dioxide, sodium bicarbonate, sodium lauryl sulfate, corn starch, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer